PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2009 | 4 |
| 2010 | 10 |
| 2011 | 12 |
| 2012 | 14 |
| 2013 | 15 |
| 2014 | 24 |
| 2015 | 15 |
| 2016 | 19 |
| 2017 | 15 |
| 2018 | 9 |
| 2019 | 18 |
| 2020 | 34 |
| 2021 | 27 |
| 2022 | 25 |
| 2023 | 15 |
| 2024 | 9 |
| 2025 | 4 |
| 2026 | 3 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Nat Rev Clin Oncol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.
- Llovet JM, Mauro E, Rimassa L, Mazzaferro V, Pinter M, Kelley RK, Chan SL, Kulik L, Pillai A, Roberts L, Sangro B, Casanovas T, Kaplan DE, Vogel A, Yarchoan M, Finn RS, Meyer T, Singal AG.
- Nat Rev Clin Oncol. Author manuscript. 2026 Jun 10;23(8):619-647. doi: 10.1038/s41571-026-01160-z.
- PMCID: PMC13665261
Llovet JM, et al.Nat Rev Clin Oncol. Author manuscript. 2026.PMCID: PMC13665261 -
Assessing the interactions between radiotherapy and antitumour immunity.
- Grassberger C, Ellsworth SG, Wilks MQ, Keane FK, Loeffler JS.
- Nat Rev Clin Oncol. Author manuscript. 2019 Jun 26;16(12):729-745. doi: 10.1038/s41571-019-0238-9.
- PMCID: PMC13492067
Grassberger C, et al.Nat Rev Clin Oncol. Author manuscript. 2019.PMCID: PMC13492067 -
Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.
- Noorani I, Mischel PS, Swanton C.
- Nat Rev Clin Oncol. Author manuscript. 2022 Sep 21;19(11):733-743. doi: 10.1038/s41571-022-00679-1.
- PMCID: PMC13271662
Noorani I, et al.Nat Rev Clin Oncol. Author manuscript. 2022.PMCID: PMC13271662 -
The development of CAR T cells for patients with CNS malignancies.
- Binder ZA, Bagley SJ, Foster JB, O'Rourke DM.
- Nat Rev Clin Oncol. Author manuscript. 2025 Dec 1;23(2):137-150. doi: 10.1038/s41571-025-01102-1.
- PMCID: PMC12854404
Binder ZA, et al.Nat Rev Clin Oncol. Author manuscript. 2025.PMCID: PMC12854404 -
Ecological management of the microbiota in patients with cancer.
- Xavier JB.
- Nat Rev Clin Oncol. Author manuscript. 2025 Jun 27;22(9):627-639. doi: 10.1038/s41571-025-01049-3.
- PMCID: PMC12690607
Xavier JB.Nat Rev Clin Oncol. Author manuscript. 2025.PMCID: PMC12690607 -
Translating biological insights into improved management of endometrial cancer.
- How JA, Jazaeri AA, Westin SN, Lawson BC, Klopp AH, Soliman PT, Lu KH.
- Nat Rev Clin Oncol. Author manuscript. 2024 Aug 28;21(11):781-800. doi: 10.1038/s41571-024-00934-7.
- PMCID: PMC12084113
How JA, et al.Nat Rev Clin Oncol. Author manuscript. 2024.PMCID: PMC12084113 -
The roles and implications of RNA m6A modification in cancer.
- Deng X, Qing Y, Horne D, Huang H, Chen J.
- Nat Rev Clin Oncol. Author manuscript. 2023 May 23;20(8):507-526. doi: 10.1038/s41571-023-00774-x.
- PMCID: PMC12466201
Deng X, et al.Nat Rev Clin Oncol. Author manuscript. 2023.PMCID: PMC12466201 -
Molecular therapies and precision medicine for hepatocellular carcinoma.
- Llovet JM, Montal R, Sia D, Finn RS.
- Nat Rev Clin Oncol. Author manuscript. 2018 Oct;15(10):599-616. doi: 10.1038/s41571-018-0073-4.
- PMCID: PMC12452113
Llovet JM, et al.Nat Rev Clin Oncol. Author manuscript. 2018.PMCID: PMC12452113 -
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.
- Marra A, Chandarlapaty S, Modi S.
- Nat Rev Clin Oncol. Author manuscript. 2024 Jan 8;21(3):185-202. doi: 10.1038/s41571-023-00849-9.
- PMCID: PMC12327481
Marra A, et al.Nat Rev Clin Oncol. Author manuscript. 2024.PMCID: PMC12327481 -
Liver cancer: time to evolve trial design after everolimus failure.
- Llovet JM.
- Nat Rev Clin Oncol. Author manuscript. 2014 Aug 5;11(9):506-7. doi: 10.1038/nrclinonc.2014.136.
- PMCID: PMC12261308
Llovet JM.Nat Rev Clin Oncol. Author manuscript. 2014.PMCID: PMC12261308